Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

P. Dewint; B.E. Hansen; E. Verhey; B. Oldenburg; D.W. Hommes; M. Pierik; C. Ponsioen; H.M. Dullemen; M. Russel; A.A. van Bodegraven; C.J. van der Woude

Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

Translated title of the contribution: Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

P. Dewint, B.E. Hansen, E. Verhey, B. Oldenburg, D.W. Hommes, M. Pierik, C. Ponsioen, H.M. Dullemen, M. Russel, A.A. van Bodegraven, C.J. van der Woude

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)
Original language	Undefined/Unknown
Pages (from-to)	292-299
Number of pages	8
Journal	Gut
Volume	63
Publication status	Published - 2014

Cite this

Dewint, P., Hansen, B. E., Verhey, E., Oldenburg, B., Hommes, D. W., Pierik, M., Ponsioen, C., Dullemen, H. M., Russel, M., van Bodegraven, A. A., & van der Woude, C. J. (2014). Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut, 63, 292-299.

@article{a4c65fe26fd341c0b77634741b4aa8b5,

title = "Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)",

author = "P. Dewint and B.E. Hansen and E. Verhey and B. Oldenburg and D.W. Hommes and M. Pierik and C. Ponsioen and H.M. Dullemen and M. Russel and {van Bodegraven}, A.A. and {van der Woude}, C.J.",

year = "2014",

language = "Undefined/Unknown",

volume = "63",

pages = "292--299",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

AU - Dewint, P.

AU - Hansen, B.E.

AU - Verhey, E.

AU - Oldenburg, B.

AU - Hommes, D.W.

AU - Pierik, M.

AU - Ponsioen, C.

AU - Dullemen, H.M.

AU - Russel, M.

AU - van Bodegraven, A.A.

AU - van der Woude, C.J.

PY - 2014

Y1 - 2014

M3 - Article

SN - 0017-5749

VL - 63

SP - 292

EP - 299

JO - Gut

JF - Gut

ER -